This prospective, randomized, single-blinded study is designed to compare the postoperative quality of recovery between propofol based total intravenous anesthesia and desflurane in patients undergoing minimally invasive nephrectomy. We hypothesize that propofol based total intravenous anesthesia can significantly improve the quality of recovery after surgery in patients with minimally invasive nephrectomy.
Adult patients undergoing elective laparoscopic or robotic assisted nephrectomy are randomly allocated to receive propofol based total intravenous anesthesia (n=75) or desflurane (n=75). The quality of recover after surgery using the QoR-15K was assessed by a investigator at postoperative day (POD) 1, 2, and 3. The primary outcome is the QoR-15K at POD 1, 2, and 3 after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
150
In the TIVA group, general anesthesia is induced and maintained with a target-controlled infusion of propofol using infusion pump (Orchestra®; Fresenius Vial, Brezins, France). In both groups, remifentanil is continuously infused throughout the surgery for balanced anesthesia, adjusted to maintain arterial pressure.
In the desflurane group, anesthesia is induced with propofol 1-2 mg/kg and maintained with desflurane (5-7 vol %). In both groups, remifentanil is continuously infused throughout the surgery for balanced anesthesia, adjusted to maintain arterial pressure.
Seoul National University Hospital
Seoul, South Korea
quality of recovery
Change in the QoR-15K score from 24 hours to 72 hours postoperatively
Time frame: at 24 hours, 48 hours, 72 hours postoperatively
Postoperative pain score
Change in the pain severity measured by the 11-pointed numeric rating scale (0: none/10: worst pain) pain score at resting/movement from 24 hours to 72 hours postoperatively
Time frame: at 24 hours, 48 hours, 72 hours postoperatively
Postoperative nausea and vomiting during the first 24 hours postoperatively
Incidence of postoperative nausea and vomiting (%)
Time frame: during the first 24 hours postoperatively
Postoperative nausea and vomiting during the 24-48 hours postoperatively
Incidence of postoperative nausea and vomiting (%)
Time frame: during the 24-48 hours postoperatively
Postoperative nausea and vomiting during the 48-72 hours postoperatively
Incidence of postoperative nausea and vomiting (%)
Time frame: during the 48-72 hours postoperatively
Total fentanyl consumption during the first 24 hours postoperatively
Change in the postoperative fentanyl consumption (mcg) via IV patient controlled analgesia from 24 hours to 72 hours postoperatively
Time frame: during the first 24 hours postoperatively
Total fentanyl consumption during the 24-48 hours postoperatively
Change in the postoperative fentanyl consumption (mcg) via IV patient controlled analgesia from 24 hours to 72 hours postoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: during the 24-48 hours postoperatively
Total fentanyl consumption during the 48-72 hours postoperatively
Change in the postoperative fentanyl consumption (mcg) via IV patient controlled analgesia from 24 hours to 72 hours postoperatively
Time frame: during the 48-72 hours postoperatively
Quality of life at early post-discharge
Change in the Quality of life measured using the EuroQoL 5-dimension 5-level scale (EQ-5D-5L) from baseline to early-postdischarge phase
Time frame: day before surgery and at 3 weeks after discharge